Adenovirus Infection
📧 Sign up to get email alerts when something new happens for Adenovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating antigen-specific cytotoxic T cells for treating opportunistic infections including EBV, CMV, adenoviru…
-
CLINICAL_TRIALS withdrawal · 2018-07-23Clinical Trial Update: Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) [Phase 1]
A Phase 1 trial of Viralym-A (Adenovirus-specific T lymphocytes) sponsored by AlloVir has been withdrawn for Adenovirus infection.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Specific Respiratory Infections as Triggers of Acute Medical Events
A completed clinical trial update examining whether specific respiratory infections act as triggers for acute medical events, including card…
-
CLINICAL_TRIALS research · 2017-01-09Clinical Trial Update: A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
A multicenter study is collecting retrospective data on patients previously diagnosed with adenovirus infection to serve as matched historic…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CTL-ADV, clinical-grade adenovirus-specific T cells, as immunotherapy after allogeneic stem cell transpl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-07-21Clinical Trial Update: Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation [Phase 1]
Phase 1 clinical trial evaluating partially HLA-matched third-party antigen-specific T-cells for preventing or treating CMV, EBV, and adenov…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) [Phase 1, Phase 2]
This clinical trial update covers Phase 1/2 testing of allogeneic virus-specific cytotoxic T-lymphocytes for adenovirus and Epstein-Barr vir…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus [Phase 1]
A Phase 1 study evaluating safety, toxicity and maximum tolerated dose of a single IV infusion of donor cytotoxic T lymphocytes specific for…
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) [Phase 1]
Phase 1 trial update on VIRAGE, rapidly generated multivirus-specific cytotoxic T-lymphocytes, for viral infections in the context of stem c…
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Collection and Testing of Respiratory Samples
A completed clinical trial assessing collection and testing of respiratory samples using the QIAGEN ResPlex II Advanced Panel and Artus Infl…
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children [Phase 2, Phase 3]
This document notes the completed Phase 2/Phase 3 trial of nitazoxanide suspension for diarrhea caused by enteric viruses in children, inclu…